Recombinant Antibodies: Advantages to the IVD & Therapeutic Markets

The recombinant antibody market is quickly expanding as researchers look for monoclonal antibody alternatives. These recombinant antibodies have inherent advantages and disadvantages. Join Rockland's Product Manager, Todd Giardiello, and our Chief Science Officer, Dr. Carl Ascoli as we discuss recombinant antibodies.